Valproic Acid Amide Derivatives for Epilepsy Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neuropathic pain and epilepsy often have severe side effects such as teratogenicity and hepatotoxicity, and there is a need for more effective medications that do not share these limitations, as many patients are resistant to existing therapies.
Innovation Solution
Development of novel amide derivatives of valproic acid with specific structural modifications, such as valpromide, valnoctamide, diisopropylacetamide, and propylisopropylacetamide, which are more potent as anticonvulsants and antiallodynic agents compared to valproic acid, while minimizing side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If valproic acid is used to treat epilepsy and neuropathic pain, then broad spectrum anticonvulsant activity is achieved, but severe side effects including teratogenicity and hepatotoxicity occur
Solution Approach 1:
The patent modifies the chemical structure of valproic acid by changing the functional group from carboxylic acid to amide, creating valpromide and its derivatives. This parameter change in molecular structure maintains the anticonvulsant activity while improving the safety profile by reducing teratogenicity and hepatotoxicity side effects.
Solution Approach 2:
The patent creates composite molecular structures by combining the valproic acid skeleton with various amide functional groups and substituents (valpromide, valnoctamide, diisopropylacetamide, propylisopropylacetamide). These composite structures achieve enhanced pharmacological activity with improved safety characteristics.
2Reliability
If valproic acid derivatives are synthesized to improve potency, then anticonvulsant and antiallodynic activity increases, but compound complexity increases
Solution Approach 1:
The patent systematically varies specific portions of the molecular structure (the amide substituent groups) while maintaining the core valproic acid skeleton. This segmentation approach allows optimization of potency through modular substitution without requiring complete redesign of the entire molecule, thus managing structural complexity.
Solution Approach 2:
The patent applies local modifications to specific positions in the molecular structure by introducing different amide derivatives at the carboxylic acid position. Each derivative (valpromide, valnoctamide, etc.) has tailored local properties that enhance potency while maintaining overall structural recognizability and managing complexity.
Data Source
AI summary
Amide derivatives of valproic acid are provided along their use in the treatment of epilepsy.